PERSTA(03395.HK):天然气管道项目料今年底投入使用
PERSTA(03395.HK)公布,Challand Pipeline Ltd於8月6日动工建设35.4公里天然气管道以及相关集气基础设施。预计总项目耗资3,600万加元。项目建设按预算如期进行,预计於今年底完成建设并投入使用。
公司已就项目完成的事项包括:获得监管部门的批准及许可,准许於建设及日後运营期间拥有地役权及通行权;95%的详细工程与设计;采购98%的管材及其他材料,预计所有采购材料按时交付。
目前约15公里管廊清理完毕并准备进行管道串接及焊接。预测近日开始交付管材并安装,随後进行检查、回填及测试。管线测试成功後,将进行管道清理并收回通行权,恢复相关区域至施工前功能。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.